1. Home
  2. AIIR vs MRVI Comparison

AIIR vs MRVI Comparison

Compare AIIR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIIR

Air Global PLC Ordinary Shares

N/A

Current Price

$6.07

Market Cap

1.1B

ML Signal

N/A

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$6.22

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIIR
MRVI
Founded
N/A
2014
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Tobacco
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AIIR
MRVI
Price
$6.07
$6.22
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.13
AVG Volume (30 Days)
10.0K
2.6M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
N/A
$12.54
Revenue Next Year
N/A
$7.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.29
$2.03
52 Week High
$8.15
$7.44

Technical Indicators

Market Signals
Indicator
AIIR
MRVI
Relative Strength Index (RSI) 46.13 46.11
Support Level $5.29 $5.67
Resistance Level $6.62 $6.55
Average True Range (ATR) 0.67 0.32
MACD 0.03 -0.13
Stochastic Oscillator 38.36 7.39

Price Performance

Historical Comparison
AIIR
MRVI

About AIIR Air Global PLC Ordinary Shares

AIR Global PLC operates in the social inhalation products sector and has operations across multiple international markets. Its portfolio includes businesses and products related to shisha and hookah, including flavored shisha molasses, hookah and shisha e-commerce platforms, and charcoal-free shisha devices. The company also conducts product research and testing in partnership with independent laboratories to support the development of inhalation-related products and technologies.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: